Fedouloff M, Hossner F, Voyle M, Ranson J, Powles J, Riley G, Sanger G
Department of Synthetic Chemistry, Smithkline Beecham Pharmaceuticals, New Frontiers Science Park, Essex CM19 5AW, Harlow, UK.
Bioorg Med Chem. 2001 Aug;9(8):2119-28. doi: 10.1016/s0968-0896(01)00120-1.
Three metabolites of N-[(1-butyl-4-piperidinyl)methyl]-3,4-dihydro-2H-[1,3]-oxazino[3,2_a]indole-10-carboxamide (SB-207266) (1) were synthesised and their pharmacological activity determined.
合成了N-[(1-丁基-4-哌啶基)甲基]-3,4-二氢-2H-[1,3]恶嗪并[3,2_a]吲哚-10-甲酰胺(SB-207266)(1)的三种代谢物,并测定了它们的药理活性。